You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search


Cancer Type: Gastrointestinal, Colorectal, Small bowel and appendix      Intent: Palliative
Regimen Category: Evidence-Informed
New Drug Funding Program
    Irinotecan - Second Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer

You might also be interested in